BUSINESSglobal
India is launching cheap, weight-loss drugs and Novo Nordisk is betting on its brands to stay on top
Single source
Updated 2 hours ago
First seen March 23, 2026 20:27:35Stay on top of this story
Follow the names and topics behind it.
Add this story's key topics to your watchlist so LyscoNews can highlight related developments and future matches.
Create a free account to sync your watchlist, saved stories, and alerts across devices.
Quick Summary
Indian generic drugmakers launch a price war against Novo Nordisk’s GLP-1 brands, Ozempic and WeGovy.